Listed

Tempest Therapeutics, Inc.: Form 10-Q for the period ended Sep 30, 2015

Filed with the SEC on Nov 5, 2015 and accepted by EDGAR at Nov 5, 2015, 16:38 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2015-09-30. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue3 months2015-07-01 to 2015-09-30$75.0kus-gaap:Revenues
Revenue9 months2015-01-01 to 2015-09-30$120.0kus-gaap:Revenues
Cost of revenue3 months2015-07-01 to 2015-09-30$940.0kus-gaap:CostOfRevenue
Cost of revenue9 months2015-01-01 to 2015-09-30$1.1mus-gaap:CostOfRevenue
Research and development3 months2015-07-01 to 2015-09-30$4.0mus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2015-01-01 to 2015-09-30$13.8mus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative3 months2015-07-01 to 2015-09-30$12.9mus-gaap:SellingGeneralAndAdministrativeExpense
Selling, general and administrative9 months2015-01-01 to 2015-09-30$37.0mus-gaap:SellingGeneralAndAdministrativeExpense
Operating income3 months2015-07-01 to 2015-09-30−$17.8mus-gaap:OperatingIncomeLoss
Operating income9 months2015-01-01 to 2015-09-30−$51.8mus-gaap:OperatingIncomeLoss
Net income3 months2015-07-01 to 2015-09-30−$17.9mus-gaap:NetIncomeLoss
Net income9 months2015-01-01 to 2015-09-30−$52.6mus-gaap:NetIncomeLoss
Diluted EPS3 months2015-07-01 to 2015-09-30−$0.66us-gaap:EarningsPerShareBasicAndDiluted
Diluted EPS9 months2015-01-01 to 2015-09-30−$1.95us-gaap:EarningsPerShareBasicAndDiluted
Operating cash flow9 months2015-01-01 to 2015-09-30−$39.0mus-gaap:NetCashProvidedByUsedInOperatingActivities
Capital expenditure9 months2015-01-01 to 2015-09-30$2.3mus-gaap:PaymentsToAcquirePropertyPlantAndEquipment
Cash and equivalentsAt period end2015-09-30$50.8mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2015-09-30$145.3mus-gaap:AssetsCurrent
Total assetsAt period end2015-09-30$152.8mus-gaap:Assets
Current liabilitiesAt period end2015-09-30$9.9mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2015-09-30$10.2mus-gaap:Liabilities
Shareholders' equityAt period end2015-09-30$142.6mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001544227-15-000004. Last ingested by Listed: Nov 15, 2026, 00:20 ET. Listed shows no prices and gives no investment advice.